Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database group

Urology

Volumn 82, Issue 1, 2013, Pages 53-59

  Teeter, Anna E ^a,b   Presti, Joseph C ^c,d   Aronson, William J ^d,e   Terris, Martha K ^d,f   Kane, Christopher J ^g   Amling, Christopher L ^h   Freedland, Stephen J ^a,b,i  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UCLA MEDICAL CENTER   (United States)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

^g UCSD MEDICAL CENTER   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOCHEMICAL RECURRENCE; CANCER MORTALITY; CANCER OF PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR NOMOGRAM; CANCER RECURRENCE; DUKE PROSTATE CENTER NOMOGRAM; HUMAN; JOHNS HOPKINS HOSPITAL NOMOGRAM; JOINT CENTER FOR PROSTATE DISEASE RESEARCH NOMOGRAM; KATTAN POSTOPERATIVE NOMOGRAM; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE CANCER SPECIFIC MORTALITY; PROSTATECTOMY;

EID: 84879528265     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2012.10.090     Document Type: Article

References (19)

1. F.R. Schroeck, L. Sun, and S.J. Freedland Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy Prostate Cancer Prostatic Dis 11 2008 371 376
2. M.W. Kattan, J.A. Eastham, and A.M. Stapleton A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer J Natl Cancer Inst 90 1998 766 771
3. M.W. Kattan, T.M. Wheeler, and P.T. Scardino Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer J Clin Oncol 17 1999 1499 1507
4. M. Han, A.W. Partin, and M. Zahurak Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer J Urol 169 2003 517 523
5. J.W. Moul, R.R. Connelly, and D.P. Lubeck Predicting risk of prostate specific antigen recurrence after radical prostatectomy with the Center for Prostate Disease Research and Cancer of the Prostate Strategic Urologic Research Endeavor databases J Urol 166 2001 1322 1327
6. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
7. A.J. Stephenson, P.T. Scardino, and J.A. Eastham Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 2005 7005 7012
8. A.E. Teeter, L.L. Bañez, and J.C. Presti Jr. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group J Urol 180 2008 1980 1984 [discussion: 1985]
9. F.R. Schroeck, W.J. Aronson, and J.C. Presti Jr. Do nomograms predict aggressive recurrence after radical prostatectomy more accurately than biochemical recurrence alone? BJU Int 103 2009 603 608
10. L.L. Bañez, R.M. Loftis, and S.J. Freedland The influence of hepatic function on prostate cancer outcomes after radical prostatectomy Prostate Cancer Prostatic Dis 13 2010 173 177
11. S.J. Freedland, E.B. Humphreys, and L.A. Mangold Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality J Clin Oncol 25 2007 1765 1771
12. C.R. Pound, A.W. Partin, and M.A. Eisenberger Natural history of progression after PSA elevation following radical prostatectomy JAMA 281 1999 1591 1597
13. W.W. Roberts, E.J. Bergstralh, and M.L. Blute Contemporary identification of patients at high risk of early prostate cancer recurrence after radical retropubic prostatectomy Urology 57 2001 1033 1037
14. S.J. Freedland, E.B. Humphreys, and L.A. Mangold Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy JAMA 294 2005 433 439
15. A.E. Teeter, J.C. Presti Jr., and W.J. Aronson Does PSADT after radical prostatectomy correlate with overall survival? A report from the SEARCH database group Urology 77 2011 149 153
16. A.E. Teeter, L. Sun, J.W. Moul, and S.J. Freedland External validation of the SEARCH model for predicting aggressive recurrence after radical prostatectomy: results from the Duke Prostate Center Database BJU Int 106 2010 796 800
17. D.P. Lubeck, M.S. Litwin, and J.M. Henning The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor Urology 48 1996 773 777
18. A.J. Stephenson, E.A. Klein, and M.W. Kattan Predicting the long-term risk of prostate cancer-specific mortality after radical prostatectomy J Clin Oncol 2009 27 (suppl; abstr 5007)
19. F.R. Schroeck, M.W. Kattan, and J.W. Moul Re-calibration and external validation of an existing nomogram to predict aggressive recurrences after radical prostatectomy BJU Int 105 2010 1654 1659